Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide with aspiration sclerotherapy for dominant hepatic cysts
NCT02048319Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2013
- Primary completion
- Nov 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pasireotide LAR in Liver Cyst, sponsored by Radboud University Medical Center. Started Dec 2013; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
Liver Cyst
Beyond the preview
Go deeper on NCT02048319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048319.